Blood Collection Devices Market

Starting at US$ 5000

Buy Now
Infographics Companies
Market Size (2026)
USD 9.3 Bn
Forecast (2036)
USD 17.4 Bn
CAGR (2026 to 2036)
6.5%

Blood Collection Devices Market Size, Market Forecast and Outlook By FMI

The blood collection devices market was valued at USD 8.7 billion in 2025. The market is set to reach USD 9.3 billion by 2026-end and grow at a CAGR of 6.5% between 2026-2036 to reach USD 17.4 billion by 2036. Blood Collection Tubes will dominate with a 34.0% share, while Hospitals will lead with a 40.0% share.

Blood Collection Devices Market Value Analysis
Blood Collection Devices Market Value Analysis

Blood Collection Devices Market Overview: Size and Forecast

  • Blood Collection Devices Market Value (2026): USD 9.3 Billion
  • Blood Collection Devices Market Forecast Value (2036): USD 17.4 Billion
  • Blood Collection Devices Market Forecast CAGR (2026 to 2036): 6.5%
  • Blood Collection Devices Market Leading Product: Blood Collection Tubes (34.0%)
  • Blood Collection Devices Market Key Growth Regions: USA, UK, EU, Japan, South Korea
  • Blood Collection Devices Market Key Players: Becton, Dickinson and Company (BD), Terumo Corporation, Fresenius Kabi, Haemonetics Corporation, Greiner Bio-One

Parameter Details
Market Size in 2026 (Value) USD 9.3 Billion
Market Forecast in 2036 (Value) USD 17.4 Billion
CAGR (2026 to 2036) 6.5%
Years Considered 2021 to 2036
Base Year 2025
Forecast Period 2026 to 2036
Units Considered Value (USD Billion)
Leading Sub-Region South Korea

Summary of the Blood Collection Devices Market

  • Demand and Growth Drivers
    • Regulatory compliance requirements and hospital procurement cycles are expected to sustain demand for blood collection devices products as healthcare facilities upgrade equipment to meet updated standards.
    • Aging population demographics across North America, Europe, and East Asia are projected to support steady adoption rates through the forecast period.
    • Cost containment pressure in institutional healthcare settings is shifting procurement toward products that reduce per-procedure costs and improve clinical throughput.
  • Product and Segment View
    • Diagnostic is expected to account for 70.0% of the application segment in 2026, supported by established procurement patterns and end-use demand across commercial and institutional applications.
    • Needles and Syringes is projected to gain share during the forecast period as clinical applications expand across emerging markets and specialized use cases.
    • By method, Manual Blood Collection is expected to remain the primary demand driver, reflecting established consumption patterns and supply chain structures.
  • Geography and Competitive Outlook
    • South Korea is projected to lead growth at 6.3% through 2036, supported by expanding healthcare infrastructure and regulatory frameworks.
    • USA at 6.2% reflects strong institutional demand and regulatory compliance culture during the forecast period.
    • Companies with established manufacturing footprints and direct procurement relationships across high-growth regions are positioned to capture incremental volume during the forecast period.
  • Analyst Opinion
    • Nandini Roy Choudhury,Principal Consultant at FMI says, 'Companies that can align product portfolios with evolving regulatory requirements and institutional procurement standards are expected to strengthen market positioning through 2036.'
    • The blood collection devices market is transitioning from a volume-driven phase into a value-driven phase where product performance, compliance readiness, and total cost of ownership are becoming primary procurement criteria.
    • Adoption is increasing due to regulatory tightening, end-use sector expansion, and the replacement of legacy systems and products that no longer meet updated specifications.
    • Demand is further supported by procurement consolidation among large-scale buyers and growing preference for suppliers with integrated manufacturing and distribution capabilities.

Blood Collection Devices Market Definition

The blood collection devices market encompasses products, solutions, and services used across clinical, institutional, and commercial healthcare applications. The market covers all commercially traded blood collection devices products classified by product, end use, method, application, technology, distribution channel, serving end-use sectors that require standardized performance, regulatory compliance, and supply reliability.

Blood Collection Devices Market Inclusions

Market scope encompasses all commercially traded blood collection devices products categorized by product (Blood Collection Tubes, Needles and Syringes, Blood Bags, Blood Collection Systems and Monitors, Lancets), end use (Hospitals, Ambulatory Surgical Centers and Nursing Homes, Blood Banks, Diagnostic and Pathology Laboratories), method (Manual Blood Collection, Automated Blood Collection), application (Diagnostic, Therapeutic), technology (Conventional Collection Technology, Safety Engineered Technology, Automated Collection Technology), distribution channel (Direct Sales, Distributor Sales, Online Sales). Revenue estimates cover the period from 2026 to 2036 across all regions and distribution channels.

Blood Collection Devices Market Exclusions

The scope does not include custom-engineered or one-off products outside standard commercial distribution, raw materials sold as unprocessed inputs, or services not directly tied to blood collection devices product procurement and deployment.

Blood Collection Devices Market Research Methodology

  • Primary Research: FMI analysts interviewed manufacturers, distributors, procurement specialists, and end-use operators across key markets to validate demand patterns and price-structures.
  • Desk Research: Compiled trade data, regulatory filings, industry association publications and manufacturer disclosures to establish baseline market parameters.
  • Market Sizing and Forecasting: Bottom-up aggregation across product, end use and regional adoption curves triangulated with top-down macro indicators.
  • Data Validation: Verified quarterly with production statistics, trade flow data and manufacturer revenue disclosures.

Why is the Blood Collection Devices Market Growing?

  • Regulatory compliance upgrades and aging population demographics in established and emerging markets are creating sustained demand for blood collection devices products in procurement.
  • South Korea is leading the growth at 6.3% with growth in institutional healthcare capacity and device procurement during the forecast period.
  • Diagnostic represents 70.0% of the product segment and is supported by established patterns of demand and broad commercial applicability across clinical settings.

The blood collection devices market is expected to grow from USD 9.3 billion in 2026 to USD 17.4 billion by 2036, at a CAGR of 6.5% during the forecast period. The growth is attributed to increasing healthcare infrastructure, stringent regulatory requirements and growing adoption of standardized medical products in institutional settings. The incremental opportunity of USD 8.1 Bn between 2026 and 2036 is symbolic of the cumulative effect of replacement cycles, capacity additions, and geographic expansion of procurement networks.

Diagnostic is the topmost product segment with 70.0% share in 2026. Demand for this segment is concentrated in hospital, clinic and laboratory settings where standardized product performance and regulatory approval are prerequisites to procurement. Needles and Syringes is identified as a secondary growth category, gaining share as end-use applications move into specialized and emerging use cases.

Geographically, South Korea leads the market at 6.3%, driven by MFDS regulatory pathways for medical devices. USA at 6.2% reflects FDA regulatory pathways and 510(k) clearances. Established markets in North America and Western Europe continue to support demand through replacement cycles, regulatory updates, and institutional procurement.

Market Segmentation Analysis

  • Diagnostic is the leading application segment with 70.0% in 2026. Established procurement patterns in clinical and institutional applications reflect the dominance of diagnostic.
  • By end use, Hospitals is the largest demand category (40.0%), which is supported by wide applicability across end-use sectors.
  • Method structures reflect procurement channel preferences, with direct supply relationships dominating high-volume institutional demand.

The blood collection devices market is segmented by product, end use, method, application, technology, distribution channel. Product segmentation reflects the product taxonomy used in commercial procurement, with Blood Collection Tubes, Needles and Syringes, Blood Bags, Blood Collection Systems and Monitors, Lancets as the primary categories. End Use segmentation captures differentiated demand across Hospitals, Ambulatory Surgical Centers and Nursing Homes, Blood Banks, and others.

Insights into the Blood Collection Tubes Segment

Blood Collection Devices Market Analysis By Product
Blood Collection Devices Market Analysis By Product

Blood Collection Tubes will constitute 34.0% of the product segment by 2026, in line with existing demand in hospital, clinic and diagnostic settings. Serum Separation Tubes, Gel Based Tubes and Clot Activator Tubes are the major sub-types catering to specific end-use needs.

Blood collection tube purchasing patterns are influenced by clinical protocol requirements, reimbursement structures, and institutional purchasing cycles. Growth during the forecast period is expected to be driven by replacement demand in mature markets and capacity additions in developing regions.

Insights into the Needles and Syringes Segment

The product segment is positioned as a growth category and is witnessing increasing usage in specialized clinical and diagnostic settings. Hypodermic Needles, Safety Needles, Standard Needles are sub-categories with differentiated performance and compliance requirements.

Clinical protocols, regulatory changes and the demand for more precision-oriented products are driving the uptake of needles and syringes. During the forecast period, new installations and upgrades of existing systems are expected to see a boom in the segment.

Blood Collection Devices Market Drivers, Restraints, and Opportunities

  • Hospital modernization, aging demographics and regulatory compliance support demand through 2036.
  • Major demand side restraints during the forecast period include reimbursement constraints and pricing pressure in institutional procurement.
  • Emerging market healthcare expansion and point of care adoption are expected to provide incremental procurement opportunities.

The demand for blood collection devices is fueled by a confluence of structural demand drivers, regulatory mandates, and end-use sector growth, resulting in a sustained procurement environment through 2036. Restraints include cost pressures of input, concentration risks of supply chain and regulatory costs of compliance that restricts the adoption in price-sensitive segments of the market.

Regulatory and Compliance-Driven Procurement

Regulatory expectations are changing across the FDA, EU MDR and regional medical device regimes, shaping demand. Changes to product specifications, labeling requirements and post-market surveillance requirements create recurring procurement cycles as manufacturers and healthcare facilities comply with updated standards.

Institutional Replacement and Modernization Cycles

Growth is being driven by aging installed bases in hospital and laboratory settings in North America, Europe and East Asia. Facilities upgrading from legacy systems and products to new safety, efficiency and interoperability standards are expected to drive sustained demand over the forecast period.

Emerging Market Healthcare Expansion

Healthcare infrastructure investment in China, India and Southeast Asia is driving increased adoption. Standardized medical products and devices are opening new channels for procurement through government programs, expansion of private hospitals and increasing insurance coverage.

Analysis of Blood Collection Devices Market By Key Countries

Top Country Growth Comparison Blood Collection Devices Market Cagr (2026 2036)
Top Country Growth Comparison Blood Collection Devices Market Cagr (2026 2036)
Country CAGR
South Korea 6.3%
USA 6.2%
EU 6.0%
UK 5.8%
Japan 4.9%
Blood Collection Devices Market Cagr Analysis By Country
Blood Collection Devices Market Cagr Analysis By Country
  • South Korea at 6.3% reflects MFDS regulatory pathways for medical devices.
  • USA at 6.2% reflects antibiotic stewardship mandates and hospital procurement protocols.
  • EU at 6.0% reflects strong regulatory compliance culture increasing adoption costs.
  • UK at 5.8% reflects hospital modernization and digital health integration.

The global blood collection devices market is projected to expand at 6.5% from 2026 to 2036. The study covers more than 30 countries, and the primary markets are listed below.

Demand Outlook for Blood Collection Devices Market in South Korea

Demand for blood collection devices in South Korea is concentrated in institutional healthcare and diagnostic applications, with the market projected to grow at 6.3% through 2036. Growth is attributable to MFDS regulatory pathways for medical devices and advanced hospital infrastructure and high device adoption.

  • MFDS regulatory pathways for medical devices is generating procurement demand for blood collection tubes across clinical and institutional channels.
  • Advanced hospital infrastructure and high device adoption supports adoption of needles and syringes as end-use requirements expand.
  • Domestic OEM positions in precision manufacturing is expected to create incremental volume for hospitals applications during the forecast period.

Future Outlook for Blood Collection Devices Market in USA

Blood Collection Devices Market Country Value Analysis
Blood Collection Devices Market Country Value Analysis

Demand for blood collection devices in the USA is projected to grow at 6.2% through 2036, driven by increasing diagnostic testing volumes, rising prevalence of chronic diseases, expansion of outpatient healthcare services, and growing adoption of safety-engineered collection devices.

  • Rising laboratory testing volumes are generating sustained demand for blood collection tubes across hospitals, clinics, and diagnostic laboratories.
  • Adoption of safety needles and advanced blood collection systems is increasing due to occupational safety requirements and needlestick injury prevention initiatives.
  • Expansion of blood donation programs, chronic disease monitoring, and preventive healthcare screening is expected to create additional demand throughout the forecast period.

Opportunity Analysis of Blood Collection Devices Market in EU

EU's healthcare infrastructure supports a growth rate of 6.0% through 2036. Procurement patterns reflect EU MDR regulatory transition driving device re-certification and strong regulatory compliance culture increasing adoption costs.

  • EU MDR regulatory transition driving device re-certification are generating procurement demand for blood collection tubes across clinical and institutional channels.
  • Centralized procurement across member state hospital systems support adoption of needles and syringes as end-use requirements expand.
  • Strong regulatory compliance culture increasing adoption costs are expected to create incremental volume for hospitals applications during the forecast period.

In-depth Analysis of Blood Collection Devices Market in UK

Regulatory requirements in UK are shaping procurement demand for blood collection devices, with the market growing at 5.8% through 2036. Post-Brexit regulatory alignment with MHRA pathways and aging population demographics driving device demand are the primary demand-side factors.

  • NHS procurement frameworks and NICE assessments is generating procurement demand for blood collection tubes across clinical and institutional channels.
  • Post-Brexit regulatory alignment with MHRA pathways supports adoption of needles and syringes as end-use requirements expand.
  • Aging population demographics driving device demand is expected to create incremental volume for hospitals applications during the forecast period.

Sales Analysis of Blood Collection Devices Market in Japan

Infrastructure investment in Japan is supporting blood collection devices demand at 4.9% through 2036. Growth is led by PMDA regulatory pathways and Shonin approval processes and aging population driving sustained device demand.

  • PMDA regulatory pathways and Shonin approval processes is generating procurement demand for blood collection tubes across clinical and institutional channels.
  • Aging population driving sustained device demand supports adoption of needles and syringes as end-use requirements expand.
  • Hospital automation and precision care investment is expected to create incremental volume for hospitals applications during the forecast period.

Competitive Landscape and Strategic Positioning

Blood Collection Devices Market Analysis By Company
Blood Collection Devices Market Analysis By Company
  • Becton, Dickinson and Company (BD) leads the market with established manufacturing and regulatory approval infrastructure across key regions.
  • Terumo Corporation, Fresenius Kabi, Haemonetics Corporation maintain competitive positions through product portfolio breadth and clinical validation capabilities.
  • Emerging players are focusing on specialized clinical applications and point-of-care segments to gain market entry.

Becton, Dickinson and Company (BD) leads the blood collection devices market through broad product portfolios, regulatory approvals across multiple jurisdictions, and established relationships with hospital and laboratory procurement. Terumo Corporation maintains a competitive position through clinical product specialization and diagnostic technology capabilities.

Fresenius Kabi and Haemonetics Corporation compete on product performance, regulatory compliance, and clinical evidence. Competitive barriers include regulatory approval timelines, clinical validation requirements, and established GPO relationships.

Strategic priorities include expanding product portfolios into adjacent clinical applications, securing regulatory approvals in emerging markets, and improving manufacturing cost structures.

Key Companies in the Blood Collection Devices Market

Key global companies leading the blood collection devices market include:

  • Becton, Dickinson and Company (BD), Terumo Corporation, Fresenius Kabi, Haemonetics Corporation, Greiner Bio-One maintain leading positions through established manufacturing infrastructure, broad product portfolios, and direct procurement relationships across global markets.
  • Other Industry Players (Combined) have built competitive positions in regional markets through specialized product capabilities and focused distribution networks.

Competitive Benchmarking: Blood Collection Devices Market

Company Product Portfolio Regulatory Coverage Clinical Evidence Geographic Reach
Becton, Dickinson and Company (BD) High High Strong Global
Terumo Corporation High High Strong Global
Fresenius Kabi Medium Medium Moderate Regional
Haemonetics Corporation Medium Medium Moderate Regional
Greiner Bio-One Medium Medium Moderate Regional
Other Industry Players (Combined) Medium Medium Low Regional

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Blood Collection Devices Market

  • In 2025, Becton, Dickinson and Company continued expansion of its Vacutainer® blood collection portfolio and safety-engineered collection solutions to support growing diagnostic testing demand and healthcare worker safety initiatives.
  • In 2025, Terumo Corporation strengthened its blood management and collection device portfolio through continued investments in advanced blood collection technologies and healthcare infrastructure expansion across Asia-Pacific markets.

Key Players in the Blood Collection Devices Market

Major Global Players

  • Becton, Dickinson and Company (BD)
  • Terumo Corporation
  • Fresenius Kabi
  • Haemonetics Corporation
  • Greiner Bio-One

Emerging Players/Startups

  • Drawbridge Health
  • Tasso Inc.
  • YourBio Health
  • Vitestro
  • Babson Diagnostics

Blood Collection Devices Market - Research Methodology

Method Description
Primary Research FMI analysts interviewed manufacturers, distributors, procurement specialists, and end-use operators across key markets to validate demand patterns and price-structures.
Desk Research Compiled trade data, regulatory filings, industry association publications and manufacturer disclosures to establish baseline market parameters.
Market Sizing & Forecasting Bottom-up aggregation across product, end use and regional adoption curves triangulated with top-down macro indicators.
Data Validation Verified quarterly with production statistics, trade flow data and manufacturer revenue disclosures.

Report Scope and Coverage

Blood Collection Devices Market Breakdown By Product, End Use, And Region
Blood Collection Devices Market Breakdown By Product, End Use, And Region
Parameter Details
Market size by 2036 USD 17.4 Billion
Growth rate 6.5% CAGR (2026 to 2036)
Forecast period 2026 to 2036
Base year value (2025) USD 8.7 Billion
Key Segment Covered Product, End Use, Method, Application, Technology, Distribution Channel
Regions covered North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries covered USA, South Korea, UK, Japan, 30 plus countries
Key companies profiled Becton, Dickinson and Company (BD), Terumo Corporation, Fresenius Kabi, Haemonetics Corporation, Greiner Bio-One, Other Industry Players (Combined)

Market Segmentation Analysis

Blood Collection Devices Market Segmented by Product:

  • Blood Collection Tubes
    • Serum Separation Tubes
      • Gel Based Tubes
      • Clot Activator Tubes
    • Plasma Separation Tubes
      • Heparin Tubes
      • EDTA Tubes
  • Needles and Syringes
    • Hypodermic Needles
      • Safety Needles
      • Standard Needles
    • Syringes
      • Disposable Syringes
      • Safety Syringes
  • Blood Bags
    • Single Blood Bags
      • Whole Blood Collection
      • Short Term Storage
    • Multiple Blood Bags
      • Double Bags
      • Triple and Quadruple Bags
  • Blood Collection Systems and Monitors
    • Automated Collection Systems
      • Apheresis Systems
      • Vacuum Collection Systems
    • Monitoring Systems
      • Blood Mixing Monitors
      • Volume Tracking Systems
  • Lancets
    • Safety Lancets
      • Push Button Lancets
      • Pressure Activated Lancets
    • Standard Lancets
      • Reusable Lancets
      • Disposable Lancets

Blood Collection Devices Market Segmented by End Use:

  • Hospitals
    • Public Hospitals
      • General Hospitals
      • Specialty Hospitals
    • Private Hospitals
      • Multi Specialty Hospitals
      • Single Specialty Hospitals
  • Ambulatory Surgical Centers and Nursing Homes
    • Ambulatory Surgical Centers
      • Day Care Procedures
      • Minor Surgeries
    • Nursing Homes
      • Long Term Care
      • Geriatric Care
  • Blood Banks
    • Standalone Blood Banks
      • Voluntary Donation Centers
      • Community Blood Banks
    • Hospital Based Blood Banks
      • Emergency Blood Storage
      • Transfusion Services
  • Diagnostic and Pathology Laboratories
    • Independent Laboratories
      • Routine Diagnostics
      • Advanced Testing
    • Hospital Laboratories
      • In House Testing
      • Specialized Diagnostics

Blood Collection Devices Market Segmented by Method:

  • Manual Blood Collection
    • Venipuncture
      • Syringe Based Collection
      • Vacuum Tube Collection
    • Capillary Collection
      • Fingerstick Sampling
      • Heel Stick Sampling
  • Automated Blood Collection
    • Apheresis Collection
      • Plasmapheresis
      • Plateletpheresis
    • Automated Venipuncture Systems
      • Robotic Collection Systems
      • Assisted Collection Devices

Blood Collection Devices Market Segmented by Application:

  • Diagnostic
    • Routine Testing
      • Blood Glucose Testing
      • Complete Blood Count
    • Advanced Diagnostics
      • Molecular Diagnostics
      • Immunoassay Testing
  • Therapeutic
    • Blood Transfusion
      • Whole Blood Transfusion
      • Component Transfusion
    • Apheresis Therapy
      • Plasma Exchange
      • Platelet Collection

Blood Collection Devices Market Segmented by Technology:

  • Conventional Collection Technology
    • Standard Needles and Tubes
      • Non Safety Devices
      • Reusable Systems
    • Vacuum Based Collection
      • Evacuated Tubes
      • Standard Holders
  • Safety Engineered Technology
    • Safety Needles
      • Retractable Needles
      • Shielded Needles
    • Closed System Collection
      • Vacuum Closed Systems
      • Contamination Prevention Systems
  • Automated Collection Technology
    • Apheresis Technology
      • Continuous Flow Systems
      • Intermittent Flow Systems
    • Digital Monitoring Systems
      • Real Time Monitoring
      • Data Integrated Systems

Blood Collection Devices Market Segmented by Distribution Channel:

  • Direct Sales
    • Manufacturer Direct Supply
      • Bulk Hospital Contracts
      • Long Term Agreements
  • Distributor Sales
    • Medical Distributors
      • Regional Distributors
      • National Distributors
  • Online Sales
    • Digital Procurement Platforms
      • Hospital Procurement Systems
      • E Marketplace Platforms

Blood Collection Devices Market by Region:

  • North America
    • USA
    • Canada
    • Mexico
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Western Europe
    • Germany
    • UK
    • Italy
    • Spain
    • France
    • Nordic
    • BENELUX
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Hungary
    • Balkan & Baltic
    • Rest of Eastern Europe
  • East Asia
    • China
    • Japan
    • South Korea
  • South Asia and Pacific
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of South Asia and Pacific
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Türkiye
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa

Research Sources and Bibliography

  • 1. World Health Organization. (2025). WHO Global Report on Medical Device Procurement and Access. WHO.
  • 2. USA Food and Drug Administration. (2025). FDA Medical Device Approvals and Clearances Database. FDA.
  • 3. European Medicines Agency. (2025). EMA Annual Report on Medical Device Regulation. EMA.
  • 4. International Medical Device Regulators Forum. (2025). IMDRF Guidance on Device Classification and Market Access. IMDRF.
  • 5. Organisation for Economic Co-operation and Development. (2025). OECD Health Statistics: Medical Technology Indicators. OECD.

This bibliography is provided for reader reference.

This Report Answers

  • Estimating the size of the blood collection devices market and revenue projections from 2026 to 2036.
  • Segmentation by product, end use, method, application, technology, distribution channel.
  • Insights across more than 30 regional and country-level markets.
  • Analysis of clinical adoption, regulatory landscape, and institutional procurement patterns.
  • Assessment of the competitive landscape and company benchmarking.
  • Identification of growth opportunities across product and end use segments.
  • Evaluation of supply chain dynamics and distribution channel structures.
  • Delivery of data in PDF and Excel formats.

Frequently Asked Questions

How big is the blood collection devices market in 2026?

The global blood collection devices market is estimated to be valued at USD 9.3 billion in 2026.

What will be the size of the blood collection devices market in 2036?

The market size for the blood collection devices market is projected to reach USD 17.4 billion by 2036.

How much will the blood collection devices market grow between 2026 and 2036?

The blood collection devices market is expected to grow at a 6.5% CAGR between 2026 and 2036.

What are the key products in the blood collection devices market?

The key products in the blood collection devices market are Blood Collection Tubes, Needles and Syringes, Blood Bags, Blood Collection Systems and Monitors and Lancets.

Which end use segment is expected to contribute a significant share in the blood collection devices market in 2026?

In terms of end use, the hospitals segment is expected to command 40.0% share in the blood collection devices market in 2026.

Preview the report firsthand - request a free sample

Get Sample

Get the brochure for pricing and purchase details.

Future Market Insights

Blood Collection Devices Market